MARKET

ZLAB

ZLAB

Zai Lab Limited
NASDAQ
25.90
-0.13
-0.50%
After Hours: 25.95 +0.05 +0.18% 19:34 08/14 EDT
OPEN
25.44
PREV CLOSE
26.03
HIGH
26.26
LOW
25.33
VOLUME
1.23M
TURNOVER
--
52 WEEK HIGH
36.77
52 WEEK LOW
15.96
MARKET CAP
2.91B
P/E (TTM)
-15.2559
1D
5D
1M
3M
1Y
5Y
1D
Morgan Stanley Sticks to Its Buy Rating for Zai Lab Ltd (1ZLB)
TipRanks · 3d ago
Citic Securities Sticks to Its Buy Rating for Zai Lab Ltd (1ZLB)
TipRanks · 3d ago
Weekly Report: what happened at ZLAB last week (0803-0807)?
Weekly Report · 5d ago
CICC Keeps Their Buy Rating on Zai Lab Ltd (1ZLB)
TipRanks · 6d ago
Citi Sticks to Their Buy Rating for Zai Lab Ltd (1ZLB)
TipRanks · 08/08 00:26
UBS Keeps Their Buy Rating on Zai Lab Ltd (1ZLB)
TipRanks · 08/08 00:25
Zai Lab Price Target Raised to $45.00/Share From $44.00 by Citigroup
Dow Jones · 08/07 20:22
Zai Lab Is Maintained at Buy by Citigroup
Dow Jones · 08/07 20:22
More
About ZLAB
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.

Webull offers Zai Lab Ltd - ADR stock information, including NASDAQ: ZLAB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZLAB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ZLAB stock methods without spending real money on the virtual paper trading platform.